Personal information

No personal information available

Activities

Employment (1)

Newcastle Upon Tyne Hospitals NHS Foundation Trust: Newcastle Upon Tyne, Newcastle upon Tyne, GB

2007-07-01 to present | Consultant (Dermatology)
Employment
Source: Self-asserted source
Philip Hampton

Education and qualifications (1)

Newcastle University: Newcastle upon Tyne, Newcastle upon Tyne, GB

2005 | BMedSci MBBS PhD
Education
Source: Self-asserted source
Philip Hampton

Works (50 of 52)

Items per page:
Page 1 of 2

Improving the Accuracy of Biologic Drug Survival Data: The Increasing Prevalence of Off-Label Dosing Must Be Considered when Reporting Drug Effectiveness and Safety

Journal of Investigative Dermatology
2023-11 | Journal article
Contributors: Amaani B. Hussain; Philip J. Hampton
Source: check_circle
Crossref

The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership

British Journal of Dermatology
2023-09-15 | Journal article
Contributors: Karen E Harman; Jag Barha; Jo R Chalmers; John K G Dart; Isobel Davies; Patricia  Ellis; Douglas Grindlay; Philip J Hampton; Sharleen Hill; Sharon Hockey et al.
Source: check_circle
Crossref

Telemedicine and e-Health in the Management of Psoriasis: Improving Patient Outcomes – A Narrative Review

Psoriasis: Targets and Therapy
2022-03 | Journal article
Contributors: Alison Havelin; Philip Hampton
Source: check_circle
Crossref

British Association of Dermatologists guidelines for the management of people with rosacea 2021*

British Journal of Dermatology
2021-10-05 | Journal article
Contributors: P.J. Hampton; J. Berth‐Jones; C.E. Duarte Williamson; R. Hay; T.A. Leslie; I. Porter; S. Rauz; D. Seukeran; R.T. Winn; M. Hashme et al.
Source: check_circle
Crossref

Sweet syndrome: A retrospective study of 64 cases and proposal of an algorithmic approach to improve investigation and management

Skin Health and Disease
2021-06 | Journal article
Part of ISSN: 2690-442X
Part of ISSN: 2690-442X
Source: Self-asserted source
Philip Hampton

Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials.

Journal of the European Academy of Dermatology and Venereology : JEADV
2021-02-09 | Journal article
Source: Self-asserted source
Philip Hampton

A retrospective cohort study reporting rituximab treatment for 33 patients with immunobullous disease

Journal of Oral Pathology & Medicine
2021-01 | Journal article
Contributors: Nicola Watson; Marco Carrozzo; Philip Hampton
Source: check_circle
Crossref

Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register.

JAMA dermatology
2021-01-01 | Journal article
Source: Self-asserted source
Philip Hampton

18239 Secukinumab treatment results in sustained improvement in absolute PASI and drug survival: 24-month follow-up from the British Association of Dermatologists Biologics and Immunomodulators Register

Journal of the American Academy of Dermatology
2020-12 | Journal article
Part of ISSN: 0190-9622
Source: Self-asserted source
Philip Hampton

Efficacité du brodalumab et du guselkumab chez les patients atteints d’un psoriasis en plaques et présentant une réponse insuffisante à l’ustékinumab : comparaison indirecte ajustée par appariement (CIAA)

Annales de Dermatologie et de Vénéréologie
2020-12 | Journal article
Part of ISSN: 0151-9638
Source: Self-asserted source
Philip Hampton

New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re‐evaluate our treatment regimens?

British Journal of Dermatology
2020-12 | Journal article
Contributors: P. Babakinejad; P.J. Hampton
Source: check_circle
Crossref

Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.

The Journal of allergy and clinical immunology
2020-10-16 | Journal article
Source: Self-asserted source
Philip Hampton

Expanding treatment options for rosacea

British Journal of Dermatology
2020-09 | Journal article
Part of ISSN: 0007-0963
Part of ISSN: 1365-2133
Source: Self-asserted source
Philip Hampton
grade
Preferred source (of 2)‎

Toxic epidermal necrolysis occurring with immune checkpoint inhibitors.

Dermatology online journal
2020-08-15 | Journal article
Source: Self-asserted source
Philip Hampton

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

The British journal of dermatology
2020-03-30 | Journal article
Source: Self-asserted source
Philip Hampton

Description of a disease activity proforma for documentation of hidradenitis suppurativa severity and distribution, and suggestions for use as a patient-reported outcome measure.

Clinical and experimental dermatology
2020-01-29 | Journal article
Source: Self-asserted source
Philip Hampton
grade
Preferred source (of 2)‎

Usability testing of MySkinSelfie: a mobile phone application for skin self‐monitoring

Clinical and Experimental Dermatology
2020-01-21 | Journal article
Contributors: P. Hampton; D. Richardson; S. Brown; C. Goodhead; K. Montague; P. Olivier
Source: check_circle
Crossref

CE2 EFFICACY OF BRODALUMAB AND GUSELKUMAB IN PATIENTS WITH PLAQUE PSORIASIS WHO ARE INADEQUATE RESPONDERS TO USTEKINUMAB: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)

Value in Health
2019-11 | Journal article
Part of ISSN: 1098-3015
Source: Self-asserted source
Philip Hampton

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.

The British journal of dermatology
2019-07-02 | Journal article
Source: Self-asserted source
Philip Hampton

Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies.

The British journal of dermatology
2018-10-04 | Journal article
Source: Self-asserted source
Philip Hampton

Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid.

The Journal of dermatological treatment
2018-09-13 | Journal article
Source: Self-asserted source
Philip Hampton
grade
Preferred source (of 2)‎

Hand eczema phototherapy pilot trial

British Journal of Dermatology
2018-07 | Journal article
Part of ISSN: 0007-0963
Source: Self-asserted source
Philip Hampton

An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema

British Journal of Dermatology
2018-07-14 | Journal article
Contributors: D. Brass; T. Fouweather; D.D. Stocken; C. Macdonald; J. Wilkinson; J. Lloyd; P.M. Farr; N.J. Reynolds; P.J. Hampton
Source: check_circle
Crossref

Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.

The British journal of dermatology
2018-07-05 | Journal article
Source: Self-asserted source
Philip Hampton

A case study of an interaction design approach to pervasive healthcare

Proceedings of the 12th EAI International Conference on Pervasive Computing Technologies for Healthcare
2018-05-21 | Conference paper
Source: Self-asserted source
Philip Hampton

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.

JAMA dermatology
2018-05-01 | Journal article
Source: Self-asserted source
Philip Hampton

Actikerall: an alternative to curettage for some seborrhoeic keratoses?

Clinical and experimental dermatology
2017-12-11 | Journal article
Source: Self-asserted source
Philip Hampton

British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.

The British journal of dermatology
2017-11-01 | Journal article
Source: Self-asserted source
Philip Hampton

High prevalence of alcohol use disorders in patients with inflammatory skin diseases

British Journal of Dermatology
2017-09 | Journal article
Contributors: K. Al‐Jefri; D. Newbury‐Birch; C.R. Muirhead; E. Gilvarry; V. Araújo‐Soares; N.J. Reynolds; E. Kaner; P.J. Hampton
Source: check_circle
Crossref

Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis.

The British journal of dermatology
2017-07-25 | Journal article
Source: Self-asserted source
Philip Hampton

Better definition of hidradenitis suppurativa subtypes is needed to progress disease-specific treatment outcomes.

The British journal of dermatology
2017-04-01 | Journal article
Source: Self-asserted source
Philip Hampton

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.

Lancet (London, England)
2017-03-06 | Journal article
Source: Self-asserted source
Philip Hampton

Haemolytic Anaemia Following High Dose Intravenous Immunoglobulin Treatment for Epidermolysis Bullosa Acquisita

Pharmacology & Pharmacy
2016 | Journal article
Part of ISSN: 2157-9423
Part of ISSN: 2157-9431
Source: Self-asserted source
Philip Hampton

Treatment of severe, chronic hand eczema: results from a UK-wide survey.

Clinical and experimental dermatology
2016-12-02 | Journal article
Source: Self-asserted source
Philip Hampton

Despite numerous recent advances in dermatological therapy, the need for inpatient dermatology care remains considerable.

Clinical and experimental dermatology
2016-12-01 | Journal article
Source: Self-asserted source
Philip Hampton

Delayed hypersensitivity reaction to intralesional triamcinolone acetonide following treatment for alopecia areata. Intradermal testing.

Journal of dermatological case reports
2015-12-31 | Journal article
Source: Self-asserted source
Philip Hampton

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.

The British journal of dermatology
2015-05-26 | Journal article
Source: Self-asserted source
Philip Hampton

Investigation of cutaneous photoadaptation to narrowband ultraviolet B.

The British journal of dermatology
2014-02-01 | Journal article
Source: Self-asserted source
Philip Hampton

The effectiveness of tap water iontophoresis for palmoplantar hyperhidrosis using a Monday, Wednesday, and Friday treatment regime.

Dermatology online journal
2013-03-15 | Journal article
Source: Self-asserted source
Philip Hampton

Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series.

Oral surgery, oral medicine, oral pathology and oral radiology
2012-05-12 | Journal article
Source: Self-asserted source
Philip Hampton

Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2).

Journal of cellular physiology
2012-04-01 | Journal article
Source: Self-asserted source
Philip Hampton

A case of strawberry gingivitis.

Clinical and experimental dermatology
2012-03-22 | Journal article
Source: Self-asserted source
Philip Hampton

Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid.

Journal of dermatological case reports
2011-12-01 | Journal article
Source: Self-asserted source
Philip Hampton

Painless unilateral ulceration of the lower leg.

Clinical and experimental dermatology
2009-06-01 | Journal article
Source: Self-asserted source
Philip Hampton

Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis.

The British journal of dermatology
2007-10-04 | Journal article
Source: Self-asserted source
Philip Hampton

A case of Schöpf-Schulz-Passarge syndrome.

Clinical and experimental dermatology
2005-09-01 | Journal article
Source: Self-asserted source
Philip Hampton

Calcineurin inhibitors for the treatment of skin disease: how do they work?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2005-05-01 | Journal article
Source: Self-asserted source
Philip Hampton

Implication for photosensitive patients of ultraviolet A exposure in vehicles.

The British journal of dermatology
2004-10-01 | Journal article
Source: Self-asserted source
Philip Hampton

Case 5. Giant-cell tumor of tendon sheath.

Clinical and experimental dermatology
2003-09-01 | Journal article
Source: Self-asserted source
Philip Hampton
grade
Preferred source (of 2)‎

Laugier-Hunziker syndrome: an important differential diagnosis for Peutz-Jeghers syndrome.

Journal of medical genetics
2003-06-01 | Journal article
Source: Self-asserted source
Philip Hampton
Items per page:
Page 1 of 2

Peer review (5 reviews for 3 publications/grants)

Review activity for American journal of clinical dermatology. (1)
Review activity for BMJ (1)
Review activity for Journal of the American Academy of Dermatology. (3)